Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Eliem Therapeutics, Inc. | 10%+ Owner | Common Stock | 5.01M | $62.6M | $12.50 | Aug 12, 2021 | Direct |
Eliem Therapeutics, Inc. | 10%+ Owner | Series A Redeemable Convertible Preferred Stock | 0 | Aug 12, 2021 | Direct | ||
Eliem Therapeutics, Inc. | 10%+ Owner | Series B Redeemable Convertible Preferred Stock | 0 | Aug 12, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ELYM | Eliem Therapeutics, Inc. | Aug 12, 2021 | 4 | $10M | 4 | Aug 16, 2021 | 10%+ Owner |
ELYM | Eliem Therapeutics, Inc. | Aug 9, 2021 | 0 | $0 | 3 | Aug 9, 2021 | 10%+ Owner |